dapivirine has been researched along with raltegravir potassium in 1 studies
| Studies (dapivirine) | Trials (dapivirine) | Recent Studies (post-2010) (dapivirine) | Studies (raltegravir potassium) | Trials (raltegravir potassium) | Recent Studies (post-2010) (raltegravir potassium) |
|---|---|---|---|---|---|
| 196 | 64 | 160 | 1,238 | 243 | 879 |
| Protein | Taxonomy | dapivirine (IC50) | raltegravir potassium (IC50) |
|---|---|---|---|
| Translocator protein | Rattus norvegicus (Norway rat) | 0.13 | |
| Integrase | Human immunodeficiency virus 1 | 0.0494 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fried, JR; Fuqua, JL; Minooei, F; Palmer, KE; Steinbach-Rankins, JM | 1 |
1 other study(ies) available for dapivirine and raltegravir potassium
| Article | Year |
|---|---|
In vitro Study on Synergistic Interactions Between Free and Encapsulated Q-Griffithsin and Antiretrovirals Against HIV-1 Infection.
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Cell Death; Cell Line; Drug Compounding; Drug Liberation; Drug Synergism; Female; HIV Infections; HIV-1; Humans; Inhibitory Concentration 50; Lectins; Nanoparticles; Particle Size; Plant Lectins; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrimidines; Raltegravir Potassium; Recombinant Proteins; Tenofovir | 2021 |